1-5890953-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015102.5(NPHP4):​c.2219G>A​(p.Arg740His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0293 in 1,602,776 control chromosomes in the GnomAD database, including 782 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R740C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.022 ( 75 hom., cov: 33)
Exomes 𝑓: 0.030 ( 707 hom. )

Consequence

NPHP4
NM_015102.5 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: -0.523

Publications

19 publications found
Variant links:
Genes affected
NPHP4 (HGNC:19104): (nephrocystin 4) This gene encodes a protein involved in renal tubular development and function. This protein interacts with nephrocystin, and belongs to a multifunctional complex that is localized to actin- and microtubule-based structures. Mutations in this gene are associated with nephronophthisis type 4, a renal disease, and with Senior-Loken syndrome type 4, a combination of nephronophthisis and retinitis pigmentosa. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]
NPHP4 Gene-Disease associations (from GenCC):
  • nephronophthisis 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Senior-Loken syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • nephronophthisis 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006297469).
BP6
Variant 1-5890953-C-T is Benign according to our data. Variant chr1-5890953-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 240967.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0223 (3388/152252) while in subpopulation NFE AF = 0.0327 (2222/68012). AF 95% confidence interval is 0.0315. There are 75 homozygotes in GnomAd4. There are 1678 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 75 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPHP4NM_015102.5 linkc.2219G>A p.Arg740His missense_variant Exon 17 of 30 ENST00000378156.9 NP_055917.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPHP4ENST00000378156.9 linkc.2219G>A p.Arg740His missense_variant Exon 17 of 30 1 NM_015102.5 ENSP00000367398.4 O75161-1
NPHP4ENST00000378169.7 linkn.*1120G>A non_coding_transcript_exon_variant Exon 14 of 27 1 ENSP00000367411.3 D6RA06
NPHP4ENST00000489180.6 linkn.2216G>A non_coding_transcript_exon_variant Exon 17 of 33 2 ENSP00000423747.1 O75161-2
NPHP4ENST00000378169.7 linkn.*1120G>A 3_prime_UTR_variant Exon 14 of 27 1 ENSP00000367411.3 D6RA06

Frequencies

GnomAD3 genomes
AF:
0.0223
AC:
3389
AN:
152134
Hom.:
75
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00569
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.0156
Gnomad ASJ
AF:
0.0452
Gnomad EAS
AF:
0.000773
Gnomad SAS
AF:
0.0238
Gnomad FIN
AF:
0.0323
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0327
Gnomad OTH
AF:
0.0220
GnomAD2 exomes
AF:
0.0247
AC:
5916
AN:
239630
AF XY:
0.0255
show subpopulations
Gnomad AFR exome
AF:
0.00500
Gnomad AMR exome
AF:
0.00994
Gnomad ASJ exome
AF:
0.0353
Gnomad EAS exome
AF:
0.000344
Gnomad FIN exome
AF:
0.0354
Gnomad NFE exome
AF:
0.0326
Gnomad OTH exome
AF:
0.0258
GnomAD4 exome
AF:
0.0300
AC:
43532
AN:
1450524
Hom.:
707
Cov.:
31
AF XY:
0.0300
AC XY:
21604
AN XY:
719656
show subpopulations
African (AFR)
AF:
0.00486
AC:
162
AN:
33308
American (AMR)
AF:
0.0102
AC:
451
AN:
44186
Ashkenazi Jewish (ASJ)
AF:
0.0366
AC:
949
AN:
25940
East Asian (EAS)
AF:
0.000483
AC:
19
AN:
39316
South Asian (SAS)
AF:
0.0251
AC:
2139
AN:
85150
European-Finnish (FIN)
AF:
0.0386
AC:
2033
AN:
52708
Middle Eastern (MID)
AF:
0.0164
AC:
94
AN:
5742
European-Non Finnish (NFE)
AF:
0.0326
AC:
36045
AN:
1104302
Other (OTH)
AF:
0.0274
AC:
1640
AN:
59872
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
2281
4562
6843
9124
11405
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1332
2664
3996
5328
6660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0223
AC:
3388
AN:
152252
Hom.:
75
Cov.:
33
AF XY:
0.0225
AC XY:
1678
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.00568
AC:
236
AN:
41564
American (AMR)
AF:
0.0156
AC:
239
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0452
AC:
157
AN:
3472
East Asian (EAS)
AF:
0.000775
AC:
4
AN:
5160
South Asian (SAS)
AF:
0.0236
AC:
114
AN:
4822
European-Finnish (FIN)
AF:
0.0323
AC:
342
AN:
10594
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0327
AC:
2222
AN:
68012
Other (OTH)
AF:
0.0217
AC:
46
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
162
325
487
650
812
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0282
Hom.:
188
Bravo
AF:
0.0194
TwinsUK
AF:
0.0294
AC:
109
ALSPAC
AF:
0.0319
AC:
123
ESP6500AA
AF:
0.00479
AC:
19
ESP6500EA
AF:
0.0335
AC:
278
ExAC
AF:
0.0248
AC:
3001
Asia WGS
AF:
0.00808
AC:
28
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 14, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Bardet-Biedl syndrome Uncertain:1
Jun 02, 2023
SN ONGC Dept of Genetics and Molecular biology Vision Research Foundation
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

Senior-Loken syndrome 4 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nephronophthisis Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Atypical hemolytic-uremic syndrome Benign:1
Dec 01, 2019
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephronophthisis 4 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
0.087
DANN
Benign
0.70
DEOGEN2
Benign
0.15
T;.
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.037
N
LIST_S2
Benign
0.71
T;T
MetaRNN
Benign
0.0063
T;T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
0.32
N;.
PhyloP100
-0.52
PrimateAI
Benign
0.20
T
PROVEAN
Benign
-0.42
N;.
REVEL
Benign
0.24
Sift
Benign
0.53
T;.
Sift4G
Benign
0.37
T;T
Polyphen
0.016
B;.
Vest4
0.13
MPC
0.086
ClinPred
0.0037
T
GERP RS
-7.2
Varity_R
0.025
gMVP
0.28
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34248917; hg19: chr1-5951013; COSMIC: COSV65394919; API